MedPath

Tryton Medical, Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

4

Active:0
Completed:2

Trial Phases

1 Phases

Not Applicable:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Not Applicable
2 (100.0%)

Tryton Post Approval Study (PAS) for the Tryton Side Branch Stent

Not Applicable
Conditions
Coronary Artery Disease
First Posted Date
2017-10-24
Last Posted Date
2019-02-26
Lead Sponsor
Tryton Medical, Inc.
Target Recruit Count
335
Registration Number
NCT03318796
Locations
🇺🇸

NC Heart and Vascular Research/UNC REX, Raleigh, North Carolina, United States

eTryton Left Main Registry Tryton Side Branch Stent® Tmt of Denovo CAD in LM and CFX Arteries

Conditions
Left Main Coronary Artery Stenosis
First Posted Date
2016-05-06
Last Posted Date
2019-04-26
Lead Sponsor
Tryton Medical, Inc.
Target Recruit Count
100
Registration Number
NCT02765646
Locations
🇩🇪

Klinikum Cobury GmbH, Coburg, Germany

Prospective, Single Blind, Rand Controlled Study to Evaluate the Safety & Effectness of Tryton Side Branch Stent Used With DES Treatmt of de Novo Bifurcation Lesions in MB & SB in Native Coronaries

Not Applicable
Completed
Conditions
Bifurcation Lesions: de Novo Lesions of the Main and Side Branch of Native Coronary Artery
Coronary Atherosclerosis of Native Coronary Artery
First Posted Date
2010-12-13
Last Posted Date
2016-10-18
Lead Sponsor
Tryton Medical, Inc.
Target Recruit Count
133
Registration Number
NCT01258972
Locations
🇺🇸

Jeffery Moses, New York City, New York, United States

News

No news found
© Copyright 2025. All Rights Reserved by MedPath